Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan:118:111441.
doi: 10.1016/j.msec.2020.111441. Epub 2020 Aug 25.

Evaluation of remodeling and regeneration of electrospun PCL/fibrin vascular grafts in vivo

Affiliations

Evaluation of remodeling and regeneration of electrospun PCL/fibrin vascular grafts in vivo

Liang Zhao et al. Mater Sci Eng C Mater Biol Appl. 2021 Jan.

Abstract

The success of artificial vascular graft in the host to obtain functional tissue regeneration and remodeling is a great challenge in the field of small diameter tissue engineering blood vessels. In our previous work, poly(ε-caprolactone) (PCL)/fibrin vascular grafts were fabricated by electrospinning. It was proved that the PCL/fibrin vascular graft was a suitable small diameter tissue engineering vascular scaffold with good biomechanical properties and cell compatibility. Here we mainly examined the performance of PCL/fibrin vascular graft in vivo. The graft showed randomly arranged nanofiber structure, excellent mechanical strength, higher compliance and degradation properties. At 9 months after implantation in the rat abdominal aorta, the graft induced the regeneration of neoarteries, and promoted ECM deposition and rapid endothelialization. More importantly, the PCL/fibrin vascular graft showed more microvessels density and fewer calcification areas at 3 months, which was beneficial to improve cell infiltration and proliferation. Moreover, the ratio of M2/M1macrophage in PCL/fibrin graft had a higher expression level and the secretion amount of pro-inflammatory cytokines started to increase, and then decreased to similar to the native artery. Thus, the electrospun PCL/fibrin tubular vascular graft had great potential to become a new type of artificial blood vessel scaffold that can be implanted in vivo for long term.

Keywords: Electrospinning; In vivo; Inflammatory cytokines; PCL/fibrin vascular grafts; Tissue remodeling and regeneration.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Preparation and observation of PCL/fibrin vascular grafts. The schematic diagram of electrospun PCL /fibrin grafts (A), macroscopic appearances of the PCL/fibrin grafts (B). Morphology of vascular grafts was observed by SEM (C and D). Scale bars represented 10 μm in C and 50 μm in D, respectively.
Fig. 2
Fig. 2
Implantation into the abdominal aorta, changes in the mechanical characteristics and morphology of the electrospun graft. Macroscopic pictures of the graft at 1, 3 and 9 months after transplantation (A). The red arrow indicated the anastomotic location of vascular graft. The appearance of the graft at 9 months after treatment with physiological saline solution (B). Gross view of the cross-sections of explanted PCL/fibrin grafts after 1, 3 and 9 months (C). (D), Compliance values of PCL/fibrin and PCL vascular grafts after 1, 3, and 9 months (n = 3). The mechanical properties of the vascular graft (n = 3) indicated the breaking strain (E), elastic modulus (F) and maximum stress (G). Changes of PCL/fibrin vascular grafts at different time periods were observed with SEM (H) and the percentage of weight retention of different grafts were measured at 1, 3 and 9 months respectively (I) (n = 3). Scale bar: (C) 1 mm. *indicated P < 0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 3
Fig. 3
Regeneration of graft vascular function after 9 months. Contraction effects of KCl and AD in native artery, PCL/fibrin graft and PCL graft (A) (n = 3); Relaxation effects of Ach and SNP (B) (n = 3). referred to statistical significance, ns indicated no statistical significance.
Fig. 4
Fig. 4
General situation of endothelialization in different grafts. The general morphology of the inner layer surface of different grafts was observed by SEM at 1 mm (A, B and C), 50 μm (D, E and F), and 10 μm (G, H and I). Red arrows indicated vascular ECs. Immunofluorescence images of PCL grafts (J and M), PCL/fibrin grafts (K and N) and native artery (L and O) stained with vWF (red) and DAPI (blue), respectively. Scale bar: 100 μm. Endothelial coverage of different grafts was calculated (P) (n = 3). p<0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 5
Fig. 5
Regeneration of vascular media layer within PCL/fibrin grafts at 9 months in vivo. HE stained images of different grafts after 9 months (A–C). Statistical analysis of cell numbers within graft different grafts (D) (n = 3). Distribution of VSMCs infiltration in different grafts under immunofluorescence test (α-SMA, green) (E-G). Fractional area of α-SMA within the graft (H) (n = 3). Immunofluorescence experiments of grafts with contractile VSMCs (SM-MHC, green) (I–K). Fractional area of SM-MHC within the graft (L) (n = 3). Cell nuclei were stained with DAPI (blue). Δ indicated the lumen. represented P < 0.05. Scale bar: 100 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 6
Fig. 6
Characterization of ECM deposition in 9 months after implantation. Microscopic photos of cross sections stained with Masson's for collagen (blue, A–C), safranin O for glycosaminoglycansin (red, E–G) and Verhoeff's for elastin (black, I–K) on different scaffolds. Total collagen, GAG, and elastin were assessed by corresponding detection kit respectively (D, H, L) (n = 3). Scale bar: 100 μm. indicated statistically significant. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 7
Fig. 7
Vascular density distribution and calcification in different grafts transplanted in abdominal aorta. Image of PCL graft and PCL/fibrin graft stained at 3 months with CD34 marker (A and B). Vessels numbers in PCL grafts and PCL/fibrin grafts at 1, 3 and 9 months was illustrated (C) (n = 3). Von Kossa staining of PCL/fibrin graft and PCL graft at 3 months (D–E). Black arrow indicated calcification. Calcification area ratio of grafts at different time points (F) (n = 3). Scale bar: 50 μm (A, B), 100 μm (D, E). indicated statistical significance. Δ indicated the graft lumen.
Fig. 8
Fig. 8
Distribution of macrophages and inflammatory-related cytokines during PCL/fibrin vascular graft remodeling. CD68, iNOS and CD206 markers were fluorescently stained (green) in PCL/fibrin graft at different time periods and native artery(A). The ratio of M2/M1 macrophages in PCL/fibrin and PCL grafts (n = 3) (B). Evaluation of inflammation related cytokines IL-4 (C), IL-10 (D), TNF-α (E), IL-6 (F) and IL-1β (G) by ELISA experiments (n = 3). P < 0.05 = . ns represented no statistical significance. Scale bar: 50 μm. Blue indicated the nucleus. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Similar articles

Cited by

References

    1. Benjamin E.J., Virani S.S., Callaway C.W., Chamberlain A.M., Chang A.R., Cheng S., Chiuve S.E., Cushman M., Delling F.N., Deo R., de Ferranti S.D., Ferguson J.F., Fornage M., Gillespie C., Isasi C.R., Jimenez M.C., Jordan L.C., Judd S.E., Lackland D., Lichtman J.H., Lisabeth L., Liu S., Longenecker C.T., Lutsey P.L., Mackey J.S., Matchar D.B., Matsushita K., Mussolino M.E., Nasir K., O'Flaherty M., Palaniappan L.P., Pandey A., Pandey D.K., Reeves M.J., Ritchey M.D., Rodriguez C.J., Roth G.A., Rosamond W.D., Sampson U.K.A., Satou G.M., Shah S.H., Spartano N.L., Tirschwell D.L., Tsao C.W., Voeks J.H., Willey J.Z., Wilkins J.T., Wu J.H., Alger H.M., Wong S.S., Muntner P. Heart disease and stroke statistics-2018 Update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492. - PubMed
    1. Wekesah F.M., Kyobutungi C., Grobbee D.E., Klipstein-Grobusch K. Understanding of and perceptions towards cardiovascular diseases and their risk factors: a qualitative study among residents of urban informal settings in Nairobi. BMJ Open. 2019;9(6) - PMC - PubMed
    1. Jaspan V.N., Hines G.L. The current status of tissue-engineered vascular grafts. Cardiol. Rev. 2015;23(5):236–239. - PubMed
    1. Kannan R.Y., Salacinski H.J., Butler P.E., Hamilton G., Seifalian A.M. Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater. 2005;74(1):570–581. - PubMed
    1. Sologashvili T., Saat S.A., Tille J.C., De Valence S., Mugnai D., Giliberto J.P., Dillon J., Yakub A., Dimon Z., Gurny R., Walpoth B.H., Moeller M. Effect of implantation site on outcome of tissue-engineered vascular grafts. Eur. J. Pharm. Biopharm. 2019;139:272–278. - PubMed

LinkOut - more resources